Moderna's COVID-19 vaccine is being reviewed on Monday by technical experts for possible WHO emergency use listing, a World Health Organization spokesman told Reuters.
"Moderna is being reviewed at the TAG (technical advisory group) meeting today," WHO spokesman Christian Lindmeier said in reply to a query. A decision on the US drugmaker's vaccine was expected in one to four days, he said.
Follow our LIVE blog for latest updates of the novel coronavirus pandemic
So far COVID-19 vaccines made by Pfizer, AstraZeneca and Johnson & Johnson have already received WHO approval, which is a signal to national regulatory authorities on a product's safety and efficacy.
Follow our full coverage of the coronavirus pandemic here.
Frequently Asked Questions
A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.
There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.
Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.